Hyperfine (NASDAQ:HYPR) Announces Quarterly Earnings Results

Posted by on Aug 6th, 2026

Hyperfine (NASDAQ:HYPR – Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.09) EPS for the quarter, hitting analysts’ consensus estimates of ($0.09), FiscalAI reports. Hyperfine had a negative net margin of 226.88% and a negative return on equity of 98.83%. The business had revenue of $3.90 million during the quarter, compared to analysts’ expectations of $4.13 million.

Here are the key takeaways from Hyperfine’s conference call:

  • Revenue rose 45% year over year to $3.9 million in Q2, while system sales increased 50% to 12 units; first-half revenue reached $7.8 million.
  • Gross margin remained above 50% for the fourth consecutive quarter at 50.7%, while first-half cash burn improved approximately 9% year over year to $16.6 million.
  • Management reiterated 2026 revenue guidance of $20 million to $22 million, gross margin of 50% to 55%, cash burn of $26 million to $28 million, and cash runway extending into 2028.
  • Growth is broadening across hospitals and IDNs, neurology offices, and international markets; the company cited initial large-IDN adoption, more than a dozen office placements, and first European Model 2 sales.
  • Hyperfine remains loss-making, reporting a $9.3 million quarterly net loss, and its stronger cash position partly reflects $10.6 million raised through its ATM program, which may create shareholder dilution.

Hyperfine Trading Up 0.2%

Shares of Hyperfine stock traded up $0.00 on Thursday, hitting $0.98. 373,535 shares of the company traded hands, compared to its average volume of 769,529. The company has a current ratio of 5.52, a quick ratio of 4.90 and a debt-to-equity ratio of 0.38. The company has a market cap of $97.48 million, a PE ratio of -2.40 and a beta of 1.42. The stock’s 50 day moving average price is $1.24 and its 200-day moving average price is $1.25. Hyperfine has a 52 week low of $0.85 and a 52 week high of $2.22.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the company. State Street Corp lifted its holdings in shares of Hyperfine by 6.1% in the 4th quarter. State Street Corp now owns 265,195 shares of the company’s stock worth $260,000 after buying an additional 15,200 shares during the period. Renaissance Technologies LLC increased its stake in shares of Hyperfine by 674.4% during the fourth quarter. Renaissance Technologies LLC now owns 364,743 shares of the company’s stock valued at $357,000 after buying an additional 317,645 shares during the period. Geode Capital Management LLC raised its holdings in shares of Hyperfine by 21.4% in the fourth quarter. Geode Capital Management LLC now owns 815,986 shares of the company’s stock valued at $799,000 after acquiring an additional 143,975 shares in the last quarter. Vanguard Group Inc. lifted its stake in Hyperfine by 5.7% in the third quarter. Vanguard Group Inc. now owns 3,511,972 shares of the company’s stock worth $5,092,000 after acquiring an additional 190,136 shares during the period. Finally, XTX Topco Ltd lifted its stake in Hyperfine by 47.9% in the fourth quarter. XTX Topco Ltd now owns 80,735 shares of the company’s stock worth $79,000 after acquiring an additional 26,165 shares during the period. 15.03% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on HYPR. BTIG Research initiated coverage on shares of Hyperfine in a report on Wednesday, April 29th. They issued a “buy” rating and a $2.00 price target for the company. B. Riley Financial reissued a “buy” rating on shares of Hyperfine in a research note on Wednesday, May 13th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Hyperfine in a research note on Friday, July 17th. Three analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $1.78.

Check Out Our Latest Stock Report on HYPR

Hyperfine Company Profile

(Get Free Report)

Hyperfine, Inc (NASDAQ: HYPR) is a medical technology company focused on expanding access to advanced neuroimaging through its portable magnetic resonance imaging (MRI) system. The company’s flagship product, Swoop®, is designed to enable bedside MRI scanning in a wide range of clinical environments, including emergency departments, intensive care units and outpatient clinics. By leveraging a compact, high-performance permanent magnet and a custom-designed gradient system, Hyperfine aims to reduce the logistical and financial barriers associated with traditional, large-scale MRI installations.

The Swoop system features a lightweight, wheeled design that can be maneuvered directly to a patient’s bedside, allowing clinicians to conduct diagnostic imaging without the need to transport critically ill or immobile patients.

Featured Articles

Earnings History for Hyperfine (NASDAQ:HYPR)

Receive News & Ratings for Hyperfine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperfine and related companies with MarketBeat.com's FREE daily email newsletter.